KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Up 5.6% in March

KORU Medical Systems, Inc. (NASDAQ:KRMDGet Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 1,050,000 shares, a growth of 5.6% from the March 15th total of 994,500 shares. Based on an average daily volume of 95,500 shares, the short-interest ratio is presently 11.0 days.

Institutional Trading of KORU Medical Systems

A number of hedge funds have recently modified their holdings of the company. B. Riley Asset Management LLC lifted its position in shares of KORU Medical Systems by 2.7% during the 3rd quarter. B. Riley Asset Management LLC now owns 833,663 shares of the company’s stock worth $2,251,000 after buying an additional 21,738 shares during the period. Eagle Asset Management Inc. grew its stake in shares of KORU Medical Systems by 70.1% during the third quarter. Eagle Asset Management Inc. now owns 54,096 shares of the company’s stock worth $146,000 after purchasing an additional 22,299 shares during the period. Mission Wealth Management LP bought a new position in KORU Medical Systems during the third quarter worth about $34,000. Meros Investment Management LP lifted its holdings in KORU Medical Systems by 12.3% during the third quarter. Meros Investment Management LP now owns 515,396 shares of the company’s stock worth $1,392,000 after acquiring an additional 56,293 shares in the last quarter. Finally, White Pine Capital LLC bought a new stake in shares of KORU Medical Systems in the third quarter valued at about $158,000. Institutional investors own 58.60% of the company’s stock.

Analyst Ratings Changes

Separately, B. Riley reissued a “buy” rating and issued a $4.00 price objective on shares of KORU Medical Systems in a research note on Thursday, March 14th.

Get Our Latest Stock Analysis on KRMD

KORU Medical Systems Stock Performance

Shares of NASDAQ KRMD opened at $2.12 on Thursday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.77 and a current ratio of 4.55. The firm has a market cap of $96.91 million, a price-to-earnings ratio of -7.31 and a beta of 0.53. The business’s 50-day simple moving average is $2.19 and its 200-day simple moving average is $2.27. KORU Medical Systems has a 52 week low of $1.98 and a 52 week high of $4.48.

KORU Medical Systems (NASDAQ:KRMDGet Free Report) last released its earnings results on Wednesday, March 13th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. KORU Medical Systems had a negative return on equity of 27.82% and a negative net margin of 48.18%. The firm had revenue of $7.19 million for the quarter, compared to analyst estimates of $7.01 million. As a group, equities research analysts expect that KORU Medical Systems will post -0.15 earnings per share for the current fiscal year.

KORU Medical Systems Company Profile

(Get Free Report)

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.

Featured Stories

Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.